Auransa is an AI-driven pharmaceutical company that develops precise medicines for patients in areas of significant unmet medical need
Investors 4
Date | Name | Website |
- | 11.2 Capit... | 112capital... |
- | DCVC | dcvc.com/ |
- | Harmonix | harmonixfu... |
- | Lux Capita... | luxcapital... |
Mentions in press and media 5
Date | Title | Description | Source |
23.03.2023 | Auransa Collaborates with USC Norris Comprehensive Cancer Ce... | AU409 trial to be conducted by Dr. Anthony El-Khoueiry at the USC Norris Comprehensive Cancer Center... | einpresswi... |
03.11.2022 | FDA Acceptance of Auransa's IND Application for AU409 for Tr... | First compound to enter clinical trial stage from a pipeline of research programs based upon Auransa... | einpresswi... |
09.08.2022 | POLARISqb and Auransa Announce Promising Results for Triple ... | POLARISqb and Auransa Partner to Tackle Women's Health Issues Auransa, Inc.,an AI biotech and Polari... | einpresswi... |
02.09.2021 | Startups should look to state-of-the-art tech to tackle dise... | Shahar Keinan Contributor Share on Twitter Shahar Keinan, co-founder and CEO of Polaris Quantum Biot... | techcrunch... |
25.06.2021 | This Startup Is Using Quantum Computing And AI To Cut Drug D... | Polaris Quantum Biotech is reinventing drug discovery, reducing the time it takes to find candidate ... | forbes.com... |